How Model-informed drug development rescue projects from a risky situation Case Study How Model-informed drug development rescue projects from a risky situation Discover how Certara’s integrated approach to model-informed drug development helps clients navigate regulatory challenges, achieve…Certara2025年6月26日
From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara Webinar From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara Certara2025年6月18日
Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis Webinar Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis Danielle Pillsbury2025年6月11日
Pharmacokinetic Modeling of Neutralizing ADA Effects in Translational Development On-Demand Webinar トランスレーショナル開発における中和ADA効果の薬物動態モデリング Certara2025年5月21日
Extrapolating AUC to Infinity BlogKnowledge Base Extrapolating AUC to Infinity AUC calculations are simple but nuanced. In this blog, we look at how to extrapolate…Certara2025年5月15日
Calculating AUC (Linear and Log-linear) BlogKnowledge Base AUC(線形および対数線形)の計算 AUC calculations are simple but nuanced. In this blog, we look at how to calculate…Certara2025年4月2日
Accumulation: What It Means and How to Calculate It BlogKnowledge Base Accumulation: What It Means and How to Calculate It Register for our July 10 webinar and discover fast, flexible, frictionless PK/PD workflows with Phoenix…Certara2025年4月2日
ビデオ Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara Certara2025年3月27日